fda warning peptides compounding bpc-157 Exciting news for coming out of today's committee hearing! The Pharmacy Advisory Committee voted 8-6 to recommend adding BPC- 157 to the 503A Bulks List for use in compounding for FDA may take an important

FDA may take an important step toward opening the peptide floodgates this week The FDA just put peptides like BPC 157, TB 500, and KPV on the clock. As a compounding pharmacist, this is literally my world and most people don't understand the regulatory nuance behind FDA is reviewing seven peptides this week, BPC 157, MOTS c, and Epitalon among them. Committee meets Thursday and Friday, and the likely outcome is tighter restrictions on compounding pharmacies. Read past the headline FDA mulls compounding for peptides previously flagged over safety risks BioSpace

SKU: 83173518691 · From clintoncounty708.com